[email protected]
CAS 132286-77-2 BOC-ASP(OALL)-OH molecular structure lightbox
CAS RN: 132286-77-2

BOC-ASP(OALL)-OH

Product Availability

Choose a grade to view its available package options.

1 package records0 with current stock1 grade group
Batch No.PackageAvailabilityLead TimeInquiry
Batchno.20250101 5g / 25g Out of stock 8-10 business days Inquiry
  • Product code: SSC-039242
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 5g
  • Available purity: ≥97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 132286-77-2
Pack Size Recorded Purity Available Qty Ship From Inquiry
5g ≥97% 0 Out of Stock Hong Kong Inquiry

132286-77-2 / (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxo-4-prop-2-enoxybutanoic acid

Standard CAS: 132286-77-2 Multi CAS: No
Basic Information Computed Properties Safety & Transport

Basic Information

CAS
132286-77-2
Multi CAS
No
Molecular Formula
C12H19NO6
Molecular Weight
273.280000
Exact Mass
273.121237
SMILES
CC(C)(C)OC(=O)N[C@@H](CC(=O)OCC=C)C(=O)O
InChI
InChI=1S/C12H19NO6/c1-5-6-18-9(14)7-8(10(15)16)13-11(17)19-12(2,3)4/h5,8H,1,6-7H2,2-4H3,(H,13,17)(H,15,16)/t8-/m0/s1
InChIKey
WZMNSEVEWIDHND-QMMMGPOBSA-N

Computed Properties

Structural Parameters

Heavy atom count
19
Fraction Csp3
0.58
Rotatable bonds
6
H-bond acceptors
5
H-bond donors
2
Molar refractivity
66.57
TPSA
101.93

LogP / Solubility

WLOGP
1.08
MLOGP
0.96
XLogP3
1
Consensus LogP
1.01
Log S (ESOL)
-1.82
Class (ESOL)
Soluble
Log S (Ali)
-2.58
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-3.06
Class (SILICOS-IT)
Poorly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.62

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Customers Also Viewed

Get In Touch

Contact Us